3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
80
Breast Neoplasms
39
Neoplasms
6
Neoplasm Metastasis
4
Leiomyoma
2
Infertility
2
Breast Neoplasms, Male
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Salivary Gland Neoplasms
1
Recurrence
1
Primary Dysautonomias
1
Patient Compliance
1
Ovarian Neoplasms
1
Osteoporosis
1
Osteitis Deformans
1
Lymphatic Metastasis
1
Kidney Diseases
1
Hypertension
1
Hyperlipidemias
1
Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
1
Hodgkin Disease
1
Hereditary Sensory and Autonomic Neuropathies
1
Hemorrhage
1
Fallopian Tube Neoplasms
1
Castrate Sensitive Prostate Cancer
1
Carcinoma, Ovarian Epithelial
1
Bulbo-Spinal Atrophy, X-Linked
1
Advanced Prostate Cancer
1
Interventions
avelumab
2
Sunitinib
2
Nutrition Assessment
2
Blood Specimen Collection
2
Axitinib
2
trifluridine tipiracil drug combination
1
trebananib
1
spartalizumab
1
pembrolizumab
1
etelcalcetide hydrochloride
1
enzalutamide
1
bicalutamide
1
aldesleukin
1
Stents
1
Sorafenib
1
Sodium Bicarbonate
1
Resistance Training
1
Receptors, Androgen
1
Plasma Exchange
1
Pharmaceutical Preparations
1
Paclitaxel
1
Oxaliplatin
1
Nephrotomy
1
Nephrostomy, Percutaneous
1
Lysine Acetyltransferase 5
1
Leuprolide
1
Kidney Transplantation
1
Interleukin-2
1
Goserelin
1
Flutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Kidney Diseases
×
Goserelin
×
Clear all
NCT05700903
2026-03-02
ARCH
University of Colorado, Denver
Phase 4
Completed
10 enrolled